Lazard Asset Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Lazard Asset Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,445	Closed	-$164K	–	2473
2024 Q1	$164K	Sell	10,445 -539	-5%	-$8.3K	﹤0.01%	1374
2023 Q4	$177K	Buy	10,984 +257	+2%	+$3.28K	﹤0.01%	1435
2023 Q3	$136K	Buy	+10,727	New	+$148K	﹤0.01%	1521
2023 Q2	–	Sell	-8,421	Closed	-$130K	–	2594
2023 Q1	$130K	Buy	+8,421	New	+$141K	﹤0.01%	1435
2022 Q4	–	Sell	-3,761	Closed	-$69K	–	2603
2022 Q3	$69K	Buy	+3,761	New	+$59K	﹤0.01%	1652
2022 Q2	–	Sell	-6,182	Closed	-$57K	–	2620
2022 Q1	$57K	Buy	+6,182	New	+$52.6K	﹤0.01%	1678
2021 Q3	–	Sell	-1,739	Closed	-$63K	–	2329
2021 Q2	$63K	Buy	1,739 +714	+70%	+$27.6K	﹤0.01%	1506
2021 Q1	$45K	Buy	+1,025	New	+$47.7K	﹤0.01%	1489

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Lazard Asset Management's DCPH Position: Q2 2024 in Review

Lazard Asset Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 10,445 shares — an estimated $164K sold.

Lazard Asset Management first reported a position in DCPH in Q1 2021 and held it in 8 quarters. The position peaked at $177K in Q4 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Lazard Asset Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Lazard Asset Management sold 10,445 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $164K.
Lazard Asset Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
Lazard Asset Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $177K in Q4 2023.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Lazard Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.